TWM
Thrive Wealth Management Portfolio holdings
AUM
$619M
This Quarter Return
+9.51%
1 Year Return
+15.53%
3 Year Return
+66.44%
5 Year Return
–
10 Year Return
–
AUM
$619M
AUM Growth
+$619M
(+18%)
Cap. Flow
+$51.4M
Cap. Flow
% of AUM
8.3%
Top 10 Holdings %
Top 10 Hldgs %
62.27%
Holding
237
New
18
Increased
119
Reduced
82
Closed
8
Top Buys
| 1 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
$11.6M |
| 2 |
Schwab US Large-Cap Growth ETF
SCHG
|
$8.45M |
| 3 |
iShares National Muni Bond ETF
MUB
|
$7.65M |
| 4 |
Vanguard Value ETF
VTV
|
$4.13M |
| 5 |
Loar Holdings
LOAR
|
$3.52M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$915K |
| 2 |
iShares International Equity Factor ETF
INTF
|
$847K |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
$310K |
| 4 |
Chemed
CHE
|
$248K |
| 5 |
Amphenol
APH
|
$218K |
Sector Composition
| 1 | Technology | 7.64% |
| 2 | Financials | 4.17% |
| 3 | Healthcare | 3.03% |
| 4 | Communication Services | 2.44% |
| 5 | Industrials | 2.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Editas Medicine
EDIT
$231M
| $73.7K | 0.01% | 33,500 | – | – |
|
227
Caribou Biosciences
CRBU
$174M
| $40.3K | 0.01% | 32,000 | – | – |
|
228
ImmunityBio
IBRX
$2.21B
| $39.7K | 0.01% | 15,041 +4,964 | +49% | +$13.1K |
|
229
OmniAb
OABI
$230M
| $30.1K | ﹤0.01% | 17,281 +1,200 | +7% | +$2.09K |
|
230
Aflac
AFL
$57.2B
| – | – | -1,836 | Closed | -$204K |
|
|
231
Chemed
CHE
$6.67B
| – | – | -403 | Closed | -$248K |
|
232
Elevance Health
ELV
$71.8B
| – | – | -492 | Closed | -$214K |
|
233
Exelon
EXC
$44.1B
| – | – | -4,541 | Closed | -$209K |
|
234
Rivian
RIVN
$16.5B
| – | – | -10,965 | Closed | -$137K |
|
235
Terns Pharmaceuticals
TERN
$609M
| – | – | -10,500 | Closed | -$29K |
|
236
Financial Select Sector SPDR Fund
XLF
$54.1B
| – | – | -4,151 | Closed | -$207K |
|
|
237
Technology Select Sector SPDR Fund
XLK
$83.9B
| – | – | -1,502 | Closed | -$310K |
|